Volume 3, Supplement 1 (Nov/Dec 2012)

Monitoring, Treatment Resistance, and Treatment Failure in Chronic Myeloid Leukemia

Breaking Barriers to Improved Outcomes

Jorge Eduardo Cortes, MD
The University of Texas MD Anderson Cancer Center
Houston, Texas

John M. Goldman, DM, FRCP, FRCPath, FMedSci
Imperial College
London, United Kingdom

Timothy P. Hughes, MD, MBBS
Centre for Cancer Biology
Adelaide, Australia

Faculty Perspectives by:

Patricia S. Ault, RN, FNP, and Mary Beth Rios, CCRP, RN
The University of Texas MD Anderson Cancer Center
Houston, Texas

Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

CNE provided by MediCom Worldwide, Inc.

This activity is supported by an unrestricted educational grant from ARIAD Pharmaceuticals, Inc.